These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36597433)

  • 1. Microfluidic Post-Insertion Method for the Efficient Preparation of PEGylated Liposomes Using High Functionality and Quality Lipids.
    Sugimoto Y; Suga T; Kato N; Umino M; Yamayoshi A; Mukai H; Kawakami S
    Int J Nanomedicine; 2022; 17():6675-6686. PubMed ID: 36597433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model.
    Suga T; Kato N; Hagimori M; Fuchigami Y; Kuroda N; Kodama Y; Sasaki H; Kawakami S
    Mol Pharm; 2018 Oct; 15(10):4481-4490. PubMed ID: 30179010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide.
    Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S
    Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic post-insertion of polyethylene glycol lipids and KK or RGD high functionality and quality lipids in milk-derived extracellular vesicles.
    Geng L; Matsumoto M; Yao F; Umino M; Kamiya M; Mukai H; Kawakami S
    Eur J Pharm Sci; 2024 Dec; 203():106929. PubMed ID: 39389168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of High Functionality and Quality Cell-penetrating Peptide Conjugated Lipid for Octaarginine Modified PEGylated Liposomes In U251 and U87 Glioma Cells.
    El-Gamal FR; Akl MA; Mowafy HA; Mukai H; Kawakami S; Afouna MI
    J Pharm Sci; 2022 Jun; 111(6):1719-1727. PubMed ID: 34863974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic synthesis of multifunctional liposomes for tumour targeting.
    Ran R; Middelberg APJ; Zhao CX
    Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells.
    Chen CW; Lu DW; Yeh MK; Shiau CY; Chiang CH
    Int J Nanomedicine; 2011; 6():2567-80. PubMed ID: 22128247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.
    Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL
    Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats.
    Chen Z; Deng J; Zhao Y; Tao T
    Int J Nanomedicine; 2012; 7():3803-11. PubMed ID: 22888235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
    Rangger C; Helbok A; von Guggenberg E; Sosabowski J; Radolf T; Prassl R; Andreae F; Thurner GC; Haubner R; Decristoforo C
    Int J Nanomedicine; 2012; 7():5889-900. PubMed ID: 23226020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyborane-encapsulated PEGylated Liposomes Prepared Using Post-insertion Technique for Boron Neutron Capture Therapy.
    Takeuchi I; Kanno Y; Uchiro H; Makino K
    J Oleo Sci; 2019; 68(12):1261-1270. PubMed ID: 31787674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
    Jaradat E; Weaver E; Meziane A; Lamprou DA
    Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifs.
    Harvie P; Dutzar B; Galbraith T; Cudmore S; O'Mahony D; Anklesaria P; Paul R
    J Liposome Res; 2003 Nov; 13(3-4):231-47. PubMed ID: 14670229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.